Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Choroidal Neovascularization Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global choroidal neovascularization market reached a value of US$ 5.3 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Choroidal neovascularization (CNV) refers to the creation of new blood vessels in the choroid layer of the eyes affecting the Bruch's membrane and retinal pigment epithelium (RPE). Its symptoms include lipid exudation, subretinal blood and fluid, and distortion, waviness and black spots in the central vision. At present, a combination of procedures, such as fluorescein angiography (FA), indocyanine green (ICG) angiography and optical coherence tomography (OCT) scanning, are utilized for diagnosing CNV. As per the results, doctors then prescribe anti-vascular endothelial growth factor (VEGF) drugs, thermal laser treatment and photodynamic therapy (PDT), to prevent the growth of the blood vessels.

The market is experiencing growth on account of the rising prevalence of age-related macular degeneration (ARMD), ocular histoplasmosis, pathologic myopia, angioid streaks, choroidal tears and inflammatory diseases of the choroid and retina. Moreover, the increasing geriatric population, which is more vulnerable to serious health conditions, is acting as another key factor bolstering the market growth. Furthermore, the growing adoption of combination drugs, along with the introduction of long-lasting anti-VEGF drugs, is propelling the demand for CNV treatments worldwide. Other factors, such as improving healthcare infrastructure and the increasing investments in research and development (R&D) activities, are also contributing to the growth of the market. However, with the spread of the coronavirus disease (COVID-19), the healthcare systems of various countries have become overburdened. Consequently, doctors are focusing on patient selection, safe injection techniques and proper sterilization to prevent the risk of contracting and transmitting the disease. In a non-emergency case, they are either rescheduling and postponing the follow-up appointments or providing remote monitoring solutions using telehealth to patients with severe conditions.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global choroidal neovascularization market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on product type, type of diagnosis, treatment type and application.

Breakup by Product Type:

  • Intravenous
  • Intravitreal
     

Breakup by Type of Diagnosis:

  • Fluorescein Angiography (FA)
  • Indocyanine Green (ICG) Angiography
  • Spectral Domain Optical Coherence Tomography (OCT)
  • Others
     

Breakup by Treatment Type:

  • Angiogenesis Inhibitors Injection
  • Photodynamic Therapy
  • Laser photocoagulation
  • Low-dose Radiation Therapy
  • Surgery
     

Breakup by Application:

  • Extreme Myopia
  • Malignant Myopic Degeneration
  • Age-Related Developments
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Bausch Health Companies Inc., Bayer AG, Gilead Sciences, Inc., F. Hoffmann-La Roche AG, MaaT Pharma, Novartis AG, Pfizer Inc., Quark Pharmaceuticals Inc. (SBI ALApharma Co. Limited), Regeneron Pharmaceuticals Inc. and Sanwa Kagaku Kenkyusho Co. Ltd. (Suzuken Co. Ltd.).

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Product Type, Type of Diagnosis, Treatment Type, Application, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Bausch Health Companies Inc., Bayer AG, Gilead Sciences, Inc., F. Hoffmann-La Roche AG, MaaT Pharma, Novartis AG, Pfizer Inc., Quark Pharmaceuticals Inc. (SBI ALApharma Co. Limited), Regeneron Pharmaceuticals Inc. and Sanwa Kagaku Kenkyusho Co. Ltd. (Suzuken Co. Ltd.)
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global choroidal neovascularization market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global choroidal neovascularization market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the type of diagnosis?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global choroidal neovascularization market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Choroidal Neovascularization Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product Type
    6.1    Intravenous
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Intravitreal
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Type of Diagnosis
    7.1    Fluorescein Angiography (FA)
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Indocyanine Green (ICG) Angiography
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Spectral Domain Optical Coherence Tomography (OCT)
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8    Market Breakup by Treatment Type
    8.1    Angiogenesis Inhibitors Injection
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Photodynamic Therapy
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Laser Photocoagulation
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Low-dose Radiation Therapy
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Surgery
        8.5.1 Market Trends
        8.5.2 Market Forecast
9    Market Breakup by Application
    9.1    Extreme Myopia
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Malignant Myopic Degeneration
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Age-Related Developments
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Bausch Health Companies Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio 
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Bayer AG
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio 
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Gilead Sciences, Inc.
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio 
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    F. Hoffmann-La Roche AG
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio 
           15.3.4.3 SWOT Analysis
        15.3.5   MaaT Pharma
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio 
        15.3.6    Novartis AG
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio 
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Pfizer Inc.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio 
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Quark Pharmaceuticals Inc. (SBI ALApharma Co., Limited)
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
        15.3.9    Regeneron Pharmaceuticals Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio 
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Sanwa Kagaku Kenkyusho Co. Ltd. (SUZUKEN CO., LTD.)
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio

List of Figures

Figure 1: Global: Choroidal Neovascularization Market: Major Drivers and Challenges
Figure 2: Global: Choroidal Neovascularization Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Choroidal Neovascularization Market: Breakup by Product Type (in %), 2020
Figure 4: Global: Choroidal Neovascularization Market: Breakup by Type of Diagnosis (in %), 2020
Figure 5: Global: Choroidal Neovascularization Market: Breakup by Treatment Type (in %), 2020
Figure 6: Global: Choroidal Neovascularization Market: Breakup by Application (in %), 2020
Figure 7: Global: Choroidal Neovascularization Market: Breakup by Region (in %), 2020
Figure 8: Global: Choroidal Neovascularization Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 9: Global: Choroidal Neovascularization (Intravenous) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Choroidal Neovascularization (Intravenous) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Choroidal Neovascularization (Intravitreal) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Choroidal Neovascularization (Intravitreal) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Choroidal Neovascularization (Fluorescein Angiography) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Choroidal Neovascularization (Fluorescein Angiography) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Choroidal Neovascularization (Photodynamic Therapy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Choroidal Neovascularization (Photodynamic Therapy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Choroidal Neovascularization (Laser photocoagulation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Choroidal Neovascularization (Laser photocoagulation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Choroidal Neovascularization (Surgery) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Choroidal Neovascularization (Surgery) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Choroidal Neovascularization (Extreme Myopia) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Choroidal Neovascularization (Extreme Myopia) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Global: Choroidal Neovascularization (Age-Related Developments) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Global: Choroidal Neovascularization (Age-Related Developments) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: North America: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: North America: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: United States: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: United States: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Canada: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Canada: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Asia Pacific: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Asia Pacific: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: China: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: China: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Japan: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Japan: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: India: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: India: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: South Korea: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: South Korea: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Australia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Australia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Indonesia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Indonesia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Europe: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Europe: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Germany: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Germany: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: France: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: France: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: United Kingdom: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: United Kingdom: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Italy: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Italy: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Spain: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Spain: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Russia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Russia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Latin America: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Latin America: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Brazil: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Brazil: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Mexico: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Mexico: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 82: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 83: Middle East and Africa: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
Figure 84: Middle East and Africa: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 85: Global: Choroidal Neovascularization Industry: SWOT Analysis
Figure 86: Global: Choroidal Neovascularization Industry: Value Chain Analysis
Figure 87: Global: Choroidal Neovascularization Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Choroidal Neovascularization Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Choroidal Neovascularization Market Forecast: Breakup by Product Type (in Million US$), 2021-2026
Table 3: Global: Choroidal Neovascularization Market Forecast: Breakup by Type of Diagnosis (in Million US$), 2021-2026
Table 4: Global: Choroidal Neovascularization Market Forecast: Breakup by Treatment Type (in Million US$), 2021-2026
Table 5: Global: Choroidal Neovascularization Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 6: Global: Choroidal Neovascularization Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Choroidal Neovascularization Market Structure
Table 8: Global: Choroidal Neovascularization Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links